Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients
Controlled, Double-blind, Randomized Clinical Trial for Prophylaxis of Postoperative Delirium in High Risk Surgical Patients With Quetiapine
Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Terminated
Due to the crisis SARS-COV-2 pandemic: recruitment of patients for the trial is stopped, healthcare pressure generated, suspend the non-essential scheduled surgical activity and on June 30, 2020 medication expired, funding has been exhausted.
Other terminated trials from Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
See all terminations from Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
This PHASE3 trial investigates Postoperative Delirium and is currently terminated or withdrawn. Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Jun 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Jun 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jul 2022 — Jul 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2022 [monthly]
Terminated PHASE3
▶ Show 5 earlier versions
-
Feb 2021 — Dec 2021 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE3
-
Jan 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jan 2019 — Jan 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
- Grupo Español de Rehabilitación Multimodal
- Instituto de Investigación Biomédica de Salamanca
For direct contact, visit the study record on ClinicalTrials.gov .